The ability of streptomycin-loaded chitosan-coated magnetic nanocomposites to possess antimicrobial and antituberculosis activities

International Journal of Nanomedicine

Volumn 10, Issue , 2015, Pages 3269-3274

  El Zowalaty, Mohamed Ezzat ^a,b   Al Ali, Samer Hassan Hussein ^a,c   Husseiny, Mohamed I ^b,d   Geilich, Benjamin M ^e,f   Webster, Thomas J ^f,g   Hussein, Mohd Zobir ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b Zagazig University   (Egypt)

^c ISRA UNIVERSITY   (Jordan)

^d CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^e Department of Bioengineering ^*  (United States)

^f Northeastern University   (United States)

^g KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Antimicrobial activity; Chitosan; Iron oxide nanoparticles; Mycobacterium tuberculosis; Streptomycin

Indexed keywords

CHITOSAN; MAGNETIC NANOPARTICLE; STREPTOMYCIN; ANTIINFECTIVE AGENT; MAGNETITE NANOPARTICLE; NANOCOMPOSITE; TUBERCULOSTATIC AGENT;

ANTIBACTERIAL ACTIVITY; ANTITUBERCULOSIS ACTIVITY; ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MAGNETIC FIELD; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; SYNTHESIS; X RAY DIFFRACTION; BACTERIUM; CHEMISTRY; DRUG EFFECTS; HUMAN;

BACTERIA (MICROORGANISMS); MYCOBACTERIUM TUBERCULOSIS; NEGIBACTERIA; POSIBACTERIA;

ANTI-INFECTIVE AGENTS; ANTITUBERCULAR AGENTS; BACTERIA; CHITOSAN; HUMANS; MAGNETITE NANOPARTICLES; NANOCOMPOSITES; STREPTOMYCIN;

EID: 84929403948     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S74469     Document Type: Article

References (19)

1. Andrade AL, Souza Dm, Pereira mC, Fabris JD, Domingues RZ. pH effect on the synthesis of magnetite nanoparticles by the chemical reduction-precipitation method. Quimica Nova. 2010;33(3):524–527.
2. Edelstein AS, Cammaratra RC. Nanomaterials: Synthesis, Properties and Applications. Boca Raton, FL: CRC Press; 1998.
3. Bumb A, Brechbiel mW, Choyke PL, et al. Synthesis and characterization of ultra-small superparamagnetic iron oxide nanoparticles thinly coated with silica. Nanotechnology. 2008;19(33):335601.
4. Bonnemain B. Superparamagnetic agents in magnetic resonance imaging: physicochemical characteristics and clinical applications a review. J Drug Target. 1998;6(3):167–174.
5. Babes L, Denizot B, Tanguy G, Le Jeune JJ, Jallet P. Synthesis of iron oxide nanoparticles used as mRI contrast agents: a parametric study. J Colloid Interface Sci. 1999;212(2):474–482.
6. Prucek R, Tuček J, Kilianová m, et al. The targeted antibacterial and antifungal properties of magnetic nanocomposite of iron oxide and silver nanoparticles. Biomaterials. 2011;32(21):4704–4713.
7. Chambers HF, Deleo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol. 2009;7(9):629–641.
8. Falagas mE, Bliziotis IA. Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era? Int J Antimicrob Agents. 2007;29(6):630–636.
9. Spellberg B, Guidos R, Gilbert D, et al; Infectious Diseases Society of America. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis. 2008;46(2):155–164.
10. Levy SB, marshall B. Antibacterial resistance worldwide: causes, challenges and responses. Nat Med. 2004;10(12 Suppl):S122–S129.
11. Huh AJ, Kwon YJ. “Nanoantibiotics”: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. J Control Release. 2011;156(2):128–145.
12. Sharma A, Kumar Arya D, Dua m, Chhatwal GS, Johri AK. Nano-technology for targeted drug delivery to combat antibiotic resistance. Expert Opin Drug Deliv. 2012;9(11):1325–1332.
13. Antimicrobial resistance: global report on surveillance 2014. World Health Organization (WHO); 2014. Available from: http://www.who.int/drugresistance/documents/surveillancereport/en/. Accessed September 17, 2014.
14. Hussein-Al-Ali SH, El Zowalaty ME, Hussein MZ, Ismail M, Webster TJ. Synthesis, characterization, controlled release, and antibacterial studies of a novel streptomycin chitosan magnetic nanoantibiotic. Int J Nanomedicine. 2014;9:549–557.
15. Zhu Y, Wu Q. Synthesis of magnetite nanoparticles by precipitation with forced mixing. J Nanoparticle Res. 1999;1(3):393–396.
16. Rüsch-Gerdes S, Pfyffer GE, Casal m, Chadwick m, Siddiqi S. mul-ticenter laboratory validation of the BACTEC mGIT 960 technique for testing susceptibilities of Mycobacterium tuberculosis to classical second-line drugs and newer antimicrobials. J Clin Microbiol. 2006;44(3):688–692.
17. Walters SB, Hanna BA. Testing of susceptibility of mycobacterium tuberculosis to isoniazid and rifampin by mycobacterium growth indicator tube method. J Clin Microbiol. 1996;34(6):1565–1567.
18. Usman mS, El Zowalaty mE, Shameli K, Zainuddin N, Salama m, Ibrahim NA. Synthesis, characterization, and antimicrobial properties of copper nanoparticles. Int J Nanomedicine. 2013;8:4467–4479.
19. Shan Z, Yang WS, Zhang X, Huang Qm, Ye H. Preparation and characterization of carboxyl-group functionalized superparamagnetic nanoparticles and the potential for bio-applications. J Braz Chem Soc. 2007;18(7):1329–1335.